Federated Hermes’s Integra LifeSciences IART Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $471K | Buy |
+49,977
| New | +$549K | ﹤0.01% | 1313 |
|
|
2025
Q2 | – | Sell |
-40,629
| Closed | -$893K | – | 2116 |
|
|
2025
Q1 | $893K | Buy |
+40,629
| New | +$955K | ﹤0.01% | 1140 |
|
|
2024
Q2 | – | Sell |
-8,341
| Closed | -$296K | – | 2078 |
|
|
2024
Q1 | $296K | Sell |
8,341
-310
| -4% | -$12.4K | ﹤0.01% | 1429 |
|
|
2023
Q4 | $377K | Sell |
8,651
-1,425
| -14% | -$56.1K | ﹤0.01% | 1404 |
|
|
2023
Q3 | $385K | Sell |
10,076
-3,769
| -27% | -$159K | ﹤0.01% | 1409 |
|
|
2023
Q2 | $569K | Buy |
13,845
+562
| +4% | +$27K | ﹤0.01% | 1328 |
|
|
2023
Q1 | $763K | Buy |
13,283
+3,114
| +31% | +$175K | ﹤0.01% | 1262 |
|
|
2022
Q4 | $570K | Sell |
10,169
-857
| -8% | -$43.6K | ﹤0.01% | 1327 |
|
|
2022
Q3 | $467K | Sell |
11,026
-699
| -6% | -$35.8K | ﹤0.01% | 1353 |
|
|
2022
Q2 | $634K | Sell |
11,725
-459
| -4% | -$27.6K | ﹤0.01% | 1304 |
|
|
2022
Q1 | $783K | Sell |
12,184
-123
| -1% | -$8.1K | ﹤0.01% | 1327 |
|
|
2021
Q4 | $824K | Sell |
12,307
-439
| -3% | -$29.7K | ﹤0.01% | 1346 |
|
|
2021
Q3 | $873K | Sell |
12,746
-54
| -0.4% | -$3.81K | ﹤0.01% | 1334 |
|
|
2021
Q2 | $873K | Sell |
12,800
-1,833
| -13% | -$130K | ﹤0.01% | 1361 |
|
|
2021
Q1 | $1.01M | Sell |
14,633
-407
| -3% | -$27.6K | ﹤0.01% | 1368 |
|
|
2020
Q4 | $976K | Buy |
15,040
+214
| +1% | +$11.5K | ﹤0.01% | 1332 |
|
|
2020
Q3 | $700K | Sell |
14,826
-1,609
| -10% | -$76.5K | ﹤0.01% | 1382 |
|
|
2020
Q2 | $772K | Sell |
16,435
-2,732
| -14% | -$134K | ﹤0.01% | 1341 |
|
|
2020
Q1 | $856K | Sell |
19,167
-423
| -2% | -$22.2K | ﹤0.01% | 1202 |
|
|
2019
Q4 | $1.14M | Sell |
19,590
-2,693
| -12% | -$160K | ﹤0.01% | 1228 |
|
|
2019
Q3 | $1.34M | Sell |
22,283
-1,762
| -7% | -$105K | ﹤0.01% | 1174 |
|
|
2019
Q2 | $1.34M | Buy |
24,045
+488
| +2% | +$25.1K | ﹤0.01% | 1203 |
|
|
2019
Q1 | $1.31M | Sell |
23,557
-1,543
| -6% | -$78.6K | ﹤0.01% | 1209 |
|
|
2018
Q4 | $1.13M | Sell |
25,100
-832
| -3% | -$45.6K | ﹤0.01% | 1243 |
|
|
2018
Q3 | $1.71M | Sell |
25,932
-920
| -3% | -$57.2K | ﹤0.01% | 1164 |
|
|
2018
Q2 | $1.73M | Buy |
+26,852
| New | +$1.66M | 0.01% | 1079 |
|
|
2017
Q1 | – | Sell |
-34,060
| Closed | -$1.46M | – | 2149 |
|
|
2016
Q4 | $1.46M | Sell |
34,060
-211,418
| -86% | -$8.59M | ﹤0.01% | 996 |
|
|
2016
Q3 | $10.1M | Sell |
245,478
-141,152
| -37% | -$5.91M | 0.03% | 425 |
|
|
2016
Q2 | $15.4M | Buy |
386,630
+117,996
| +44% | +$4.25M | 0.05% | 328 |
|
|
2016
Q1 | $9.05M | Buy |
268,634
+268,630
| +6,715,750% | +$8.37M | 0.03% | 432 |
|
|
2015
Q4 | $1K | Sell |
4
-34
| -89% | -$1.06K | ﹤0.01% | 2011 |
|
|
2015
Q3 | $1K | Sell |
38
-11,348
| -100% | -$355K | ﹤0.01% | 1905 |
|
|
2015
Q2 | $314K | Buy |
+11,386
| New | +$303K | ﹤0.01% | 1426 |
|
|
2014
Q3 | – | Sell |
-5,238
| Closed | -$101K | – | 2018 |
|
|
2014
Q2 | $101K | Sell |
5,238
-39,327
| -88% | -$733K | ﹤0.01% | 1578 |
|
|
2014
Q1 | $838K | Sell |
44,565
-14,155
| -24% | -$273K | ﹤0.01% | 1222 |
|
|
2013
Q4 | $1.15M | Buy |
58,720
+812
| +1% | +$14.9K | ﹤0.01% | 1124 |
|
|
2013
Q3 | $953K | Sell |
57,908
-4,489
| -7% | -$72K | ﹤0.01% | 1143 |
|
|
2013
Q2 | $934K | Buy |
+62,397
| New | +$914K | ﹤0.01% | 1121 |
|
Other funds holding IART
RCMNY
PCMI
VPM
VCM
Federated Hermes's IART Position: Q1 2026 in Review
Federated Hermes opened a new position in Integra LifeSciences (IART) in Q1 2026: 49,977 shares worth $471K. The stake represents ﹤0.01% of the portfolio and ranks #1313 among its holdings. This is a return to the name: Federated Hermes previously reported a position in IART as recently as Q1 2025.
Federated Hermes first reported a position in IART in Q2 2013 and has held it in 38 quarters since. The position peaked at $15.4M in Q2 2016. 201 funds tracked by Wall St. Rank hold IART as of Q1 2026.
- Federated Hermes held 49,977 shares of Integra LifeSciences worth $471K as of Q1 2026.
- Integra LifeSciences was a new Federated Hermes position in Q1 2026.
- Integra LifeSciences made up ﹤0.01% of Federated Hermes's portfolio in Q1 2026, its #1313 holding.
- Federated Hermes first reported a position in Integra LifeSciences in Q2 2013 and has held it in 38 quarters since.
- Federated Hermes's Integra LifeSciences position peaked at $15.4M in Q2 2016.
- 201 funds tracked by Wall St. Rank held Integra LifeSciences as of Q1 2026.
Based on Federated Hermes's 13F filing for Q1 2026, filed 11 May 2026.